SOURCE: Almac Clinical Technologies

May 24, 2007 08:30 ET

Almac Clinical Technologies Speaks on 'Quality' at 43rd DIA Annual Meeting

YARDLEY, PA -- (MARKET WIRE) -- May 24, 2007 -- Continuing efforts to share their expertise within the clinical trial arena, Almac Clinical Technologies is pleased to announce that three of their own staff will be speaking at this year's DIA Annual Meeting in Atlanta next month.

James Huang, Director of Quality Assurance and Regulatory Affairs, will participate in Wednesday's session titled "Validation Quality and Costs: It's All about the Risk." In his presentation, James will illustrate a 4-layered model for the qualification, validation, and compliance of global clinical IT systems. Attendees will also benefit from a case study discussion that demonstrates an integrated global eClinical trial system qualification methodology.

Marsha Rehrer, Director of Software Testing, will participate in the session titled "Measurement of Quality: A Necessary Step" on Thursday morning. Almac realizes that clinical trial software timelines are decreasing; however, the need for quality remains paramount. Marsha will provide management techniques for measuring software quality and integrity, while simultaneously creating a quantitative framework for software testing process improvement. These techniques will help the software testing organization identify and re-forge its weak links into strong, efficient, seamless chains of productivity.

Theresa Hummel-Krallinger, Director of Training and Organizational Development, will lead the session "Getting the Message Across: It's All about the Presentation" on Tuesday morning. Theresa will demonstrate several web-based tools that are sure to add value and 'pizzazz' to your training and presentations. Participants will have the chance to interact with trainers throughout the pharmaceutical industry, and share different techniques that bring continued education to your company.

Jim Murphy, President of Almac Clinical Technologies, said: "Almac is proud of its industry leading commitment to system and service quality. The combination of a strong quality framework, sound software testing methodology and innovative training techniques has enabled Almac to drive continuous improvement in our business while expanding to meet the rapidly growing demand for our services."

About Almac

Almac Clinical Technologies is a division of the Almac Group that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization, tracking and clinical supply management, iDiary for phone-based electronic patient reported outcome data collection, and iTrial EDC™ for electronic case report form data collection.

Almac Group and its affiliated companies (Almac Diagnostics, Almac Sciences, Almac Clinical Services, Almac Clinical Technologies and Almac Pharma Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.

Contact Information

  • Contact:

    Carl Whyte
    Stakeholder Communications
    +44 (0)28 9033 9949
    Email Contact

    Meghan Adams
    Almac Clinical Technologies
    + 1 267 685 4284